DrugPatentWatch Database Preview

Patent: 10,280,230

« Back to Dashboard

Summary for Patent: 10,280,230

Title:	Use of human cells of myeloid leukemia origin for expression of antibodies
Abstract:	The invention relates to a method for producing a protein molecule composition having a defined glycosylation pattern, comprising (a) introducing in a host cell which is an immortalized human blood cell at least one nucleic acid encoding at least a part of said protein; and (b) culturing said host cell under conditions which permit the production of said protein molecule composition; and (c) isolating said protein molecule composition.
Inventor(s):	Goletz; Steffen (Berlin, DE), Danielczyk; Antje (Berlin, DE), Baumeister; Hans (Berlin, DE), Stahn; Renate (Berlin, DE), Loeffler; Anja (Eichhorst, DE), Stoeckl; Lars (Berlin, DE)
Assignee:	Glycotope GmbH (Berlin, DE)
Application Number:	14/703,498
Patent Claims:	see list of patent claims

Details for Patent 10,280,230

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Microbix Biosystems	KINLYTIC	urokinase	INJECTABLE;INJECTION	021846	001	1978-01-16		Glycotope GmbH (Berlin, DE)	2026-09-10	DISCN		search
Microbix Biosystems	KINLYTIC	urokinase	INJECTABLE;INJECTION	021846	002	1978-01-16		Glycotope GmbH (Berlin, DE)	2026-09-10	DISCN		search
Microbix Biosystems	KINLYTIC	urokinase	INJECTABLE;INJECTION	021846	003	1978-01-16		Glycotope GmbH (Berlin, DE)	2026-09-10	DISCN		search

International Patent Family for US Patent 10,280,230

Country	Patent Number	Estimated Expiration
Australia	2007294122
Brazil	PI0716997
Canada	2662226